Cite
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
MLA
Minculescu, Lia, et al. “Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.” Frontiers in Immunology, vol. 10, Aug. 2019, p. 1997. EBSCOhost, https://doi.org/10.3389/fimmu.2019.01997.
APA
Minculescu, L., Marquart, H. V., Ryder, L. P., Andersen, N. S., Schjoedt, I., Friis, L. S., Kornblit, B. T., Petersen, S. L., Haastrup, E., Fischer-Nielsen, A., Reekie, J., & Sengelov, H. (2019). Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Frontiers in Immunology, 10, 1997. https://doi.org/10.3389/fimmu.2019.01997
Chicago
Minculescu, Lia, Hanne Vibeke Marquart, Lars Peter Ryder, Niels Smedegaard Andersen, Ida Schjoedt, Lone Smidstrup Friis, Brian Thomas Kornblit, et al. 2019. “Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.” Frontiers in Immunology 10 (August): 1997. doi:10.3389/fimmu.2019.01997.